Wilson Wu
About Wilson Wu
Wilson Wu serves as the Senior Vice President of Biometrics at Arcus Biosciences, where he applies his expertise in innovative trial designs and statistical methods to enhance drug development. With a strong background in biostatistics and leadership roles at various pharmaceutical companies, he has significantly contributed to obtaining global approvals for multiple pharmaceutical products.
Work at Arcus Biosciences
Wilson Wu serves as the Senior Vice President of Biometrics at Arcus Biosciences, a position he has held since 2023. In this role, he is responsible for overseeing the biometrics function, which includes biostatistics, programming, and data management. His leadership is crucial in navigating the complexities of drug development in a fast-paced environment. Wu's expertise in innovative trial designs and statistical methods supports the company's mission to accelerate drug development in various therapeutic areas.
Previous Experience at AstraZeneca
Prior to his current role, Wilson Wu worked at AstraZeneca from 2008 to 2013 as the Biostatistics Head for Infectious Diseases and Vaccines. During his five years in Gaithersburg, Maryland, he led biostatistical efforts that contributed to the development of vaccines and treatments for infectious diseases. His work involved the application of advanced statistical methods to support clinical trials and regulatory submissions.
Background and Education
Wilson Wu holds a Doctor of Philosophy (PhD) in Biostatistics from The University of Texas Health Science Center at Houston (UTHealth Houston). He also earned a Master of Science (MS) in Statistics from Texas A&M University. His educational background provides a strong foundation for his expertise in statistical analysis and trial design, which he applies throughout his career in the biopharmaceutical industry.
Leadership Roles in Biometrics
Throughout his career, Wilson Wu has held several leadership positions in biometrics across multiple organizations. He served as the Vice President of Biometrics at Halozyme Therapeutics, Inc. from 2013 to 2019 and as the Senior Vice President of Biometrics at Denovo Biopharma for 10 months in 2020. His extensive experience includes building and leading biometrics functions, advocating for evidence-based decision-making, and playing a key role in obtaining global approvals for pharmaceutical products.
Expertise in Statistical Methods
Wilson Wu is recognized for his expertise in innovative trial designs and statistical methods. His work has significantly contributed to accelerated drug development in therapeutic areas such as oncology, hematology, and infectious diseases. Wu advocates for evidence-based strategic decision-making through statistical and quantitative analysis, which enhances the effectiveness of clinical trials and regulatory interactions.